SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is drawing attention after a recent rebound that traders say held its gains, with bullish technical setups and positioning ahead of earnings. The upbeat view contrasts with concerns that high rates and a sluggish housing market could continue to weigh on renovation demand.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers sharp rally to fresh multi-year highs is drawing attention, with traders citing rotation into defensive, dividend-paying pharma stocks and positioning ahead of the quarterly report. Bulls see a technical breakout and pipeline momentum, while skeptics warn the move may meet resistance and point to patent-expiration and growth concerns.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 77,397.34014094 USD and is up 0.28 over the last 24 hours. It is currently trading on 12773 active market(s) with $12,152,377,915.37 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoin is drawing attention amid concerns over Binances reported major hack and paused withdrawals, with traders debating whether damaged exchange trust could trigger further selling. Others argue the market is absorbing the shock and point to Binances reported reimbursement progress and planned withdrawal reopening as reasons for optimism.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Attention centers on expected Q3 results and the Phase 3 QUILT-2.005 topline for ANKTIVA plus BCG in BCG-naive bladder cancer; the trial is database-locked, with a supplemental filing planned if results support it. Bullish traders see the readout and ANKTIVAs expanded bladder-cancer label as growth catalysts, while others question commercial uptake and point to competition, short-selling, and broader market weakness to explain the volatility.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is drawing attention as traders use the leveraged inverse Nasdaq ETF to hedge or bet on further weakness in tech, citing concerns about AI spending and valuations alongside recent tech-led selling. The community is divided: some expect more downside, while others warn that rumors of a U.S.Iran deal and a possible market rebound could reverse gains in the short ETF.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The Dow is being discussed amid volatile, uneven trading across major indexes, with traders watching Fed policy and rising Treasury yields as pressures on equities. Some see relative strength in the Dow as money rotates away from tech, while others warn that inflation, oil-market risks and weakening momentum could deepen a selloff.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Discussion centers on BioCrysts upcoming quarterly results and whether continued ORLADEYO growth can support the stock despite its weak performance. Traders are also looking ahead to Navenibart and Netherton data, while debating managements acquisition strategy and expressing frustration over dilution and limited shareholder returns; buyout talk remains speculative.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disneys quarterly results and outlook are drawing attention, with traders highlighting stronger streaming profitability and resilient theme-park performance. The reaction is mixed: some see support for a turnaround, while others point to the stocks persistent range-bound price action and difficulty holding gains.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS is drawing attention ahead of its upcoming earnings report, with traders watching whether guidance holds and how management addresses pressure on the pharmacy benefit management business. Some see the recent pullback as a potential technical rebound setup, while others remain cautious after the stocks recent selling.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

A sharp volatility spike has lifted UVIX, drawing traders seeking a hedge against a broader market pullback. The community is split between expecting volatility to persistciting concerns about oil, interest rates and geopolitical risksand warning that UVIX can quickly lose value as volatility fades and its leveraged futures exposure decays.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oak Hill Capital to Acquire Majority Stake in Wyyerd from Carlyle

Oak Hill Capital to Acquire Majority Stake in Wyyerd from Carlyle Oak Hill Capital to Acquire Majority Stake in Wyyerd from CarlylePR NewswirePHOENIX, Oct. 29, 2026 Strategic investment leverages Oak Hill's expertise scaling fiber businesses to accelerate Wyyerd's network expansion across Arizona...

Carlyle Warns Private Credit Could Get Too Deep Into AI as $1 Trillion Financing Wave Looms

Carlyle Group Inc. (NASDAQ: CG) is warning that private credit could become overly exposed to artificial intelligence infrastructure.read more...

Carlyle, Insight Partners, and JMI Equity Unveil Exiger's Complete AI-Built Transformation

Carlyle, Insight Partners, and JMI Equity Unveil Exiger's Complete AI-Built Transformation Carlyle, Insight Partners, and JMI Equity Unveil Exiger's Complete AI-Built Transformation PR Newswire WASHINGTON, Sept. 10, 2026 Category Leader Launches Autonomous AI Development Platform to Bring...

How Carlyle's Wealth Push Opens New Avenues for Fee Revenue Growth

CG is expanding its wealth platform through acquisitions and partnerships to broaden private-market access. Can this drive fee revenue growth?

Carlyle (CG) Down 2.3% Since Last Earnings Report: Can It Rebound?

Carlyle (CG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Carlyle and Dynasty Equity Announce Closing of Minority Investments in the Seattle Seahawks

Carlyle (NASDAQ: CG) and Dynasty Equity today announced the closing of their minority investments in the Seattle Seahawks in support of the Khosla familys purchase of the team. The investments received approval from the National Football League (NFL) at the Special League Meeting on Wednesday...

IVZ or CG: Which Is the Better Value Stock Right Now?

IVZ vs. CG: Which Stock Is the Better Value Option?

AZENTA ANNOUNCES LEADERSHIP TRANSITION

AZENTA ANNOUNCES LEADERSHIP TRANSITION AZENTA ANNOUNCES LEADERSHIP TRANSITION PR Newswire BURLINGTON, Mass., Aug. 24, 2026 Current Director Dr. Martin Madaus Appointed Interim CEOCompany Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue GuidanceBURLINGTON, Mass., Aug. 24, 2026...

Castelion Raises $1 Billion Series C to Scale Production of Low-Cost Hypersonic Weapons

Castelion Raises $1 Billion Series C to Scale Production of Low-Cost Hypersonic Weapons Castelion Raises $1 Billion Series C to Scale Production of Low-Cost Hypersonic Weapons PR Newswire TORRANCE, Calif., Aug. 19, 2026 FundingdrivesBlackbeardtomaximumproductionrateandacceleratesanew longer-range...

The Carlyle Group, Inc. is a global investment firm. It operates through the following segments: Global Private Equity (GPE), Global Credit (GC), and Carlyle AlpInvest. The GPE segment focuses on buyout and growth capital funds, which pursue a variety of corporate investments of different sizes and growth potentials. The GC segment includes funds and vehicles that pursue investment strategies including loans and structured credit, direct lending, opportunistic credit, distressed credit, aircraft financing and servicing, infrastructure debt, insurance solutions, and global capital markets. The Carlyle AlpInvest segment provides comprehensive investment opportunities and resources for investors and clients to build private equity portfolios through fund of funds, secondary purchases or financings of existing portfolios, and managed co-investment programs. The company was founded by William Elias Conway Jr., Daniel Anthony D'Aniello, and David Mark Rubenstein in 1987 and is headquartered in Washington, DC.

Carlyle Group Inc (The)

Carlyle Confirms Deal To Buy Majority Stake In AI-Focused IT Consultancy Firm Adastra

Equity

Neutral Sentiment

U.S. asset management and financial services company Carlyle Group (CG) has agreed to acquire a majority stake in data analytics and IT consultancy company Adastra Group SE.Founded in 2000 and headquartered in Prague, Czech Republic and Toronto, Canada, Adastra helps customers unlock business value through data-driven innovation. It also guides clients through their artificial intelligence (AI) journey.The financial terms of the deal weren’t disclosed, although Bloomberg, which previously reported the deal rumor, said the consideration involved is $400 million, including debt.The company’s clients are primarily from the financial services, insurance, automotive, manufacturing, TMT (technology, media and telecom), retail, and professional services verticals.&nbsp;It has more than 2,000 employees across several market-facing and global delivery centres.Adastra CEO Rob Turner and COO Pavel Kysela, in a joint statement, said, “This is an exciting and transformative step for Adastra.”“With Carlyle’s deep experience and global network, we believe we can unlock a new phase of growth for the business and capitalise on the substantial opportunity in the global market for AI, Data, and Cloud services.”Carlyle said the equity investment will be provided jointly by Carlyle Europe Technology Partners V and Carlyle Asia Partners Growth II.Adastra’s founders, Jan Mrazek, Jan Červinka, and Petr Jech, will retain their respective minority stakes and stay on in the company.It has among its clientele high-profile companies, including Audi, Volkswagen, AstraZeneca, T-Mobile, and HSBC.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/figma-sets-ipo-pice-range-at-25-28-retail-eyes-multi-bagger-potential/ch8M7K4R5s7">Figma Sets IPO Price Range At $25–$28: Retail Traders Eye Multi-Bagger Potential</a>

Handshake in business office (Representative stock photo courtesy of Shannon Fagan via Getty Images)

Adastra has among its clientele high-profile companies, including Audi, Volkswagen, AstraZeneca, T-Mobile, and HSBC.

iShares US Technology ETF

Vanguard Total Stock Market ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$40.18
Prev Close	$40.57
Open	$40.41
Dividend Yield	2.37%
50-Day Moving Average	$41.47
Beta	1.74
Avg. Volume	3.36M
PE Ratio	41.62

52-Week High	$67.30
52-Week Low	$35.41
Market Capitalization	$14.32B
EPS (Annual)	$2.18
Price to Book	2.71
Revenue Per Employee	$1.92M

Feed

News

Sentiment

Earnings

Fundamentals

Info

CG Fundamentals